ArticleClinical kidney journal2021

Tyrosine kinase inhibitor-induced hypertension-marker of anti-tumour treatment efficacy or cardiovascular risk factor?

Anastasia G Ptinopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.